Patanase and Prilosec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Patanase (olopatadine hydrochloride) and Prilosec (omeprazole). Common drug interactions include multiple allergies among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Patanase and Prilosec. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.

What is Patanase?

Patanase has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 1,514 Patanase users. Check the latest studies of Patanase.

What is Prilosec?

Prilosec has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 175,285 Prilosec users. Check the latest studies of Prilosec.



On Jul, 11, 2026

93 people who take Patanase and Prilosec together, and have interactions are studied.

Patanase and Prilosec drug interactions.

What are the common drug interactions of Patanase and Prilosec, by gender? *:

female:

  1. Multiple allergies (allergy to multiple agents)
  2. Otitis media (inflammation of the middle ear)
  3. Otorrhoea (discharge from the ear)
  4. Pneumonia
  5. Rash
  6. Respiratory tract infection
  7. Skin irritation
  8. Skin swelling
  9. Swelling
  10. Upper respiratory tract infection

male:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Hypertension (high blood pressure)
  4. Weight decreased
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Asthenia (weakness)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Bone loss
  10. Conjunctivitis allergic (inflammation of the conjunctiva due to allergy)

What are the common drug interactions of Patanase and Prilosec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Migraine (headache)
  2. Nephrolithiasis (calculi in the kidneys)
  3. Juvenile idiopathic arthritis (a subset of arthritis seen in childhood)
  4. Still's disease (a rare illness that causes high fevers, rash, and joint pain)

20-29:

n/a

30-39:

  1. Oedema mouth (swelling of mouth)
  2. Salivary gland enlargement (increased size of salivary gland)

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Abdominal discomfort
  4. Abdominal distension
  5. Abdominal pain upper
  6. Administration site reaction
  7. Agitation (state of anxiety or nervous excitement)
  8. Anxiety
  9. Back pain
  10. Blood prolactin increased

50-59:

  1. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  2. Abdominal pain
  3. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  4. Asthma
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Disability
  7. Food allergy
  8. Foot fracture
  9. Glycosuria (excretion of glucose into the urine)
  10. Hallucination (an experience involving the perception of something not present)

60+:

  1. Chronic kidney disease
  2. Renal tubular necrosis (death of kidney tubules)
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Hypertension (high blood pressure)
  5. Diarrhoea
  6. Peripheral swelling
  7. Renal injury (kidney injury)
  8. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  9. Conjunctivitis allergic (inflammation of the conjunctiva due to allergy)
  10. Dysphonia (speech disorder attributable to a disorder of phonation)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 23 people, 24.73%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 17 people, 18.28%
  3. High Blood Pressure: 12 people, 12.90%
  4. Asthma: 11 people, 11.83%
  5. High Blood Cholesterol: 8 people, 8.60%
  6. Pain: 7 people, 7.53%
  7. Hypersensitivity: 7 people, 7.53%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 7.53%
  9. Stress And Anxiety: 6 people, 6.45%
  10. Depression: 6 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Patanase and Prilosec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Patanase and Prilosec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Patanase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prilosec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Patanase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prilosec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on olopatadine hydrochloride and omeprazole (the active ingredients of Patanase and Prilosec, respectively), and Patanase and Prilosec (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: